WHO-UCLA auditory verbal learning test: Normative data for Spanish-speaking adults in the United States
NeuroRehabilitation · 2024
DOI: 10.3233/nre-240090 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroRehabilitation, 2024. Verfasst von Juan Carlos Arango-Lasprilla und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. Hauptthemen laut MEDLINE: Hispanic or Latino, Verbal Learning. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Hispanics are a significant demographic in the U.S., with diverse cultures and languages. Assessing cognition in this group is complex as cultural and linguistic factors have been found to affect test performance. OBJECTIVE: To generate normative data on the World Health Organization-University of California Los Angeles Auditory Verbal Learning Test (WHO-UCLA AVLT) in a sample of Spanish-speaking Hispanics residing in the U.S. METHODS: The sample included 245 Spanish-speaking individuals aged 18–80 across the U.S. (California, Connecticut, Florida, Indiana, New Jersey, Oregon, Virginia, and Wisconsin). Participants were administered the WHO-UCLA AVLT as part of a comprehensive neuropsychological battery. A Bayesian regression approach was used to estimate normative data, including covariates found to be important for predicting performances on measures of learning and memory. RESULTS: Bayesian models showed a logarithmic link between education and all WHO-UCLA AVLT trials, except recognition. For delayed recall, increased Spanish proficiency benefited women’s performance exclusively. Time in the U.S. was a significant predictor for total recall, indicating worse performance with longer residency. CONCLUSION: Recognizing cultural factors like language proficiency and duration of U.S. residence is essential for accurately evaluating cognitive function among Spanish-speaking Hispanics. This research emphasizes the importance of accounting for cultural nuances in developing norms for neuropsychological assessments, thereby improving their relevance and effectiveness in diverse communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Health Science, Public University of Navarre, Pamplona, Spain.
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Clinical Psychology Program, Carlos Albizu University, Miami Campus, Miami, FL, USA.
- Department of Health and Wellness Design, School of Public Health, Indiana University, Bloomington, IN, USA.
- School of Data Science, University of Virginia, Charlottesville, VA, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Arango-Lasprilla, J. C., Rivera, D., Rodriguez, M. J., Christ, B. R., Moreno, O., Usuga, D. R., Olabarrieta-Landa, L., Perrin, P. B., Carrión, C. I., Morel Valdés, G. M., Krch, D., Amaya, A., Drago, C. I., García, P., & Rivera, P. M. (2024). WHO-UCLA auditory verbal learning test: Normative data for Spanish-speaking adults in the United States. NeuroRehabilitation. https://doi.org/10.3233/nre-240090
Vancouver
Arango-Lasprilla JC, Rivera D, Rodriguez MJ, Christ BR, Moreno O, Usuga DR, et al. WHO-UCLA auditory verbal learning test: Normative data for Spanish-speaking adults in the United States. NeuroRehabilitation. 2024. doi:10.3233/nre-240090
BibTeX
@article{ArangoLasprilla2024,
author = {Arango-Lasprilla, Juan Carlos and Rivera, Diego and Rodriguez, Miriam J and Christ, Bryan R and Moreno, Oswaldo and Usuga, Daniela Ramos and Olabarrieta-Landa, Laiene and Perrin, Paul B and Carrión, Carmen I and Morel Valdés, Gloria M and Krch, Denise and Amaya, Ariana and Drago, Christin I and García, Patricia and Rivera, Patricia M},
title = {WHO-UCLA auditory verbal learning test: Normative data for Spanish-speaking adults in the United States},
journal = {NeuroRehabilitation},
year = {2024},
doi = {10.3233/nre-240090}
}
EUVIMED